Articles From: Addus HomeCare To Present At The Oppenheimer 25th Annual Healthcare Conference to Yandex Launches Project to Provide Big Data Solutions to Businesses


DOWNERS GROVE, Ill., Dec.
Sign-up for Addus HomeCare To Present At The Oppenheimer 25th Annual Healthcare Conference investment picks
MILWAUKEE, Dec.
Sign-up for ARI and Shopatron Partner to Deliver Unified eCommerce Solution investment picks
NEW YORK , Dec.
Sign-up for Sree Kotay and Christine Petersen Join Bankrate Board of Directors investment picks
Tyler Technologies, Inc. (NYSE: TYL) has signed a contract with Tioga County, New York, for Tyler’s Munis ® enterprise resource planning (ERP) solution.
Sign-up for Tioga County, New York, Chooses Tyler Technologies’ ERP Solution investment picks
ATHENS, Greece, Dec.
Sign-up for Diana Shipping Inc. Announces the Acquisition of a New-Building Capesize Dry Bulk Vessel investment picks
LONDON, Dec.
Sign-up for Willis Adds ABSL to Willis Commercial Network investment picks
Webco Industries, Inc. (OTC: WEBC) today reported results for its fiscal 2015 first quarter ended October 31, 2014.
Sign-up for Webco Industries, Inc. Reports Fiscal 2015 First Quarter Results investment picks
Vertex Energy, Inc. (NASDAQ: VTNR ), an environmental services company that recycles industrial waste streams and off-specification commercial chemical products, today announced that it has completed the acquisition of all the assets of Heartland Group Holdings, LLC (“Heartland”), a used-oil collection and re-refining company with its primary operations in Columbus, Ohio.
Sign-up for Vertex Energy Completes Acquisition of Heartland Group Holdings investment picks
Five9, Inc. (NASDAQ:FIVN), a leading provider of cloud contact center software, will host and present at a number of events throughout December to share best practices and strategies for contact center professionals.
Sign-up for Five9 to Host and Keynote at Contact Center Industry Events investment picks
NetScout Systems, Inc. (NASDAQ: NTCT), today announced that it has been named to Forbes’ annual list of America’s Best Small Companies 2014 .
Sign-up for Forbes Names NetScout One of America’s Best Small Companies for the Third Year investment picks
JACKSONVILLE, Fla., Dec.
Sign-up for Stein Mart, Inc. Declares Quarterly Dividend investment picks
Presentations at SABCS and SUO Reveal Company's Ability to Detect Breast and Bladder Cancers in Blood and Urine, Respectively SAN ANTONIO , Dec.
Sign-up for Genomic Health Advances Development of Novel Liquid Biopsy-Based Cancer Tests investment picks
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=11G028115-001&sourceType=1 http://www.marketwire.com/library/MwGo/2014/12/8/11G028115/WANdisco,_Plc.-238433252687.jpg SAN RAMON, CA--(Marketwired - December 09, 2014) - WANdisco (LSE: WAND), a leading provider of continuous-availability software for global enterprises to meet the challenges of Big Data, today announced the release of Non-Stop Hadoop version 1.9.10 with support for Cloudera's CDH 5.2 and Hortonworks' HDP 2.2. Non-Stop Hadoop 1.9.10 also introduces an intuitive global administration console with easy-to-configure directory-level selective replication across any combination of any number of data centers.
Sign-up for WANdisco Releases Non-Stop Hadoop 1.9.10 With Seamless Integration With Hortonworks & Cloudera investment picks
http://media.marketwire.com/attachments/201106/76308_CalixlogoRGBon-screen.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1163720&ProfileId=051205&sourceType=1 RALEIGH, NC --
Sign-up for Calix Unleashes the First Gigabit Community Networks in Oregon and Michigan investment picks
PHOENIX and VANCOUVER, British Columbia, Dec.
Sign-up for FDA Approves a Safer Way to Administer Vaccines investment picks
Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) today reported updated data from a Phase 1 monotherapy study of duvelisib (IPI-145), an inhibitor of phosphoinositide-3-kinase (PI3K)-delta and PI3K-gamma , which showed activity among patients with relapsed/refractory indolent non-Hodgkin lymphoma (iNHL), a fatal type of blood cancer.
Sign-up for Infinity Reports New Results from Phase 1 Study of Investigational Oncology Compound Duvelisib at the American Society of Hematology Annual Meeting investment picks
Shareholder rights law firm Johnson & Weaver, LLP has commenced an investigation into whether certain officers and directors of Conn’s, Inc. (NASDAQ: CONN) violated state or federal laws.
Sign-up for CONN’S INVESTOR ALERT: Shareholder Rights Law Firm Johnson & Weaver, LLP Announces Investigation of Conn’s, Inc.; Investors Encouraged to Contact the Firm Regarding Legal Rights investment picks
ARLINGTON, Va., Dec.
Sign-up for MCG Capital Announces Final Results of Its Tender Offer investment picks
Gift Cards Are Now Available at Select USPS Post Office Locations PLEASANTON, Calif.
Sign-up for Blackhawk Network and United States Postal Service (USPS) Work Together to Make Holiday Gifting Even Easier investment picks
GlycoMimetics, Inc. (NASDAQ:GLYC) today announced that data from research related to the company’s E-Selectin antagonist (GMI-1271), focusing on its potential in treating blood cancers and coagulation disorders, were highlighted this week through four oral presentations and one poster session at the 2014 American Society of Hematology Annual Meeting in San Francisco.
Sign-up for GlycoMimetics Highlights Potential Therapeutic Benefits of Its Novel E-Selectin Antagonist at 56th ASH Annual Meeting investment picks
Terreno Realty Corporation (NYSE:TRNO), an acquirer, owner and operator of industrial real estate in six major coastal U.S. markets, announced today the pricing of its public offering of 8,500,000 shares of common stock at a price per share of $19.60. The underwriters have been granted a 30-day option to purchase up to an additional 1,275,000 shares of common stock.
Sign-up for Terreno Realty Corporation Announces Pricing of Public Follow-On Offering of 8,500,000 Shares of Common Stock investment picks
Celgene Corporation (NASDAQ:CELG) today announced that data were presented from a phase 1b/2 study of ISTODAX® (romidepsin) combined with cyclophosphamide, doxorubicin, vincristine and prednisone (CHOP) in patients with peripheral t-cell lymphoma were presented during the 56th American Society of Hematology annual meeting.
Sign-up for Combination of ISTODAX® (romidepsin) and Standard CHOP Demonstrates a Complete Response in 51% of Patients with Peripheral T-Cell Lymphoma investment picks
Myriad myRisk™ Hereditary Cancer Test Finds 105 Percent More Mutations Myriad myChoice ™ HRD Predicted Platinum Response in Early TNBC BRAC Analysis ® Predicted Platinum Response in Metastatic TNBC SALT LAKE CITY, Dec.
Sign-up for Three New Myriad Studies Highlighted at 2014 San Antonio Breast Cancer Symposium investment picks
MOSCOW and AMSTERDAM, Netherlands, Dec.
Sign-up for Yandex Launches Project to Provide Big Data Solutions to Businesses investment picks
Premium Membership: Features and Benefits
Wide-Moat Screener for Stocks

Put a moat around your portfolio. Sniff out the most promising opportunities that can ride through any market.

Gold Medalist Screener for Funds

Narrow the available universe of 5000 funds to the top rated gold and silver. Then, sort for manager tenure, expense ratio, risk and return to create your own index-beating fund watchlist.

Thousands of Premium Analyst Reports

While many of our competitors measure a stock's worth with a computer program, Morningstar's staff of 150+ analyst sift through company fillings, financial data and a wealth of other sources to deliver an unvarnished review of any investment. In fact, twelve Morningstar analysts have been recognized by WSJ as "Best on the Street" in the US.

Premium Portfolio Monitor

Make decisions with confidence. Load your investments into our research center and automatically connect to all our proprietary tools and data points.

Mobile

Never be without critical research. Free with your active membership, take our Premium data and guidance wherever you go with Morningstar for iPad®, iPhone®, and Android apps.

Morningstar's Guarantee

We're looking out for you. If after your 14-day free trial, you find that a Morningstar Premium membership is not for you, cancel any time and we'll be happy to refund the unused portion - no questions asked.

Go Premium!
Exclusive Premium Member Benefits
Get the best thinking of 150+ disciplined
objective, experienced analysts-dedicated to
specific industries and securities.
+2,500 Analyst Reports
Wide Moat Screener for Stocks
Medalist Screener for Funds
Premium Portfolio Manager with X-Ray & Monitor
Premium eNewsletters
Morningstar Basic Benefits (All)
Sign up now - No charge for the first 14 days
Articles From: Addus HomeCare To Present At The Oppenheimer 25th Annual Healthcare Conference to Yandex Launches Project to Provide Big Data Solutions to Businesses
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices |  Most Recent